↓ Skip to main content

A phase I study of high-dose rosuvastatin with standard dose erlotinib in patients with advanced solid malignancies

Overview of attention for article published in Journal of Translational Medicine, March 2016
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
52 Mendeley